阿瑞匹坦在大麻致吐综合征中的新作用
Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome.
作者信息
Parvataneni Swetha, Varela Lionel, Vemuri-Reddy Sireesha M, Maneval Mandy L
机构信息
Internal Medicine, Geisinger Health System, Lewistown, USA.
Family Medicine, Geisinger Health System, Lewistown, USA.
出版信息
Cureus. 2019 Jun 4;11(6):e4825. doi: 10.7759/cureus.4825.
Abstract
Cannabis hyperemesis syndrome (CHS) is a clinical syndrome associated with prolonged and regular cannabis use. CHS is characterized by recurrent episodes of intractable nausea and vomiting. Given the overlap with other medical conditions and the frequent delay in diagnosis, finding an effective anti-emetic regimen for symptomatic control of CHS can be challenging. We report a case study where aprepitant (Emend) was successfully used as an anti-emetic in the treatment of CHS when all other common anti-emetics failed.
摘要
大麻性呕吐综合征（CHS）是一种与长期规律使用大麻相关的临床综合征。CHS的特征是反复出现难以控制的恶心和呕吐。鉴于其与其他疾病的重叠以及诊断常常延迟，找到一种有效的止吐方案来对症控制CHS可能具有挑战性。我们报告了一个病例研究，当所有其他常用止吐药均无效时，阿瑞匹坦（意美）成功用作止吐药治疗CHS。
相似文献
1
Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome.阿瑞匹坦在大麻致吐综合征中的新作用
Cureus. 2019 Jun 4;11(6):e4825. doi: 10.7759/cureus.4825.
2
Cannabis hyperemesis syndrome: an update on the pathophysiology and management.大麻性呕吐综合征：病理生理学与管理的最新进展
Ann Gastroenterol. 2020 Nov-Dec;33(6):571-578. doi: 10.20524/aog.2020.0528. Epub 2020 Sep 16.
3
Cannabis Hyperemesis Syndrome in a Young Patient: A Case Report and Literature Review.一名年轻患者的大麻呕吐综合征：病例报告及文献综述
Cureus. 2023 Aug 21;15(8):e43868. doi: 10.7759/cureus.43868. eCollection 2023 Aug.
4
Running Out of Options: Rhabdomyolysis Associated with Cannabis Hyperemesis Syndrome.无计可施：大麻过度使用综合征相关横纹肌溶解症。
J Gen Intern Med. 2017 Dec;32(12):1407-1409. doi: 10.1007/s11606-017-4111-1. Epub 2017 Jun 29.
5
The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.氟哌利多在大麻素呕吐综合征治疗中的效用。
Clin Toxicol (Phila). 2019 Sep;57(9):773-777. doi: 10.1080/15563650.2018.1564324. Epub 2019 Feb 7.
6
Rare but relevant: Cannabinoid hyperemesis syndrome.罕见但相关：大麻素呕吐综合征。
Addiction. 2025 Feb;120(2):380-384. doi: 10.1111/add.16693. Epub 2024 Oct 14.
7
Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area.大麻素呕吐综合征在急诊科的表现：在一个主要城区的两年多中心回顾性图表审查。
CJEM. 2018 Jul;20(4):550-555. doi: 10.1017/cem.2017.381. Epub 2017 Aug 24.
8
Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.大麻素呕吐综合征：急诊科的病理生理学与治疗
J Emerg Med. 2018 Mar;54(3):354-363. doi: 10.1016/j.jemermed.2017.12.010. Epub 2018 Jan 5.
9
A hot bath to calm what ails you: the Cannabis Hyperemesis Syndrome.洗个热水澡舒缓不适：大麻呕吐综合征。
Acute Med. 2012;11(1):23-4.
10
Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.急诊科治疗大麻素呕吐综合征：综述。
Am J Ther. 2018 May/Jun;25(3):e357-e361. doi: 10.1097/MJT.0000000000000655.
引用本文的文献
1
Mitigating the Risk of QTc Prolongation When Using Haloperidol for Acute Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents and Young Adults.在青少年和青年成人中使用氟哌啶醇急性治疗大麻素呕吐综合征时降低QTc延长风险。
J Clin Med. 2024 Dec 30;14(1):163. doi: 10.3390/jcm14010163.
2
From Chronic Cannabis to Cyclic Chaos: A Glimpse Into Cannabinoid Hyperemesis Syndrome.从慢性大麻使用到周期性混乱：深入了解大麻素呕吐综合征。
Cureus. 2024 Jul 18;16(7):e64828. doi: 10.7759/cureus.64828. eCollection 2024 Jul.
3
Cannabis Hyperemesis Syndrome: What Do We Know?大麻呕吐综合征：我们了解什么？
Med Cannabis Cannabinoids. 2024 May 3;7(1):86-90. doi: 10.1159/000539182. eCollection 2024 Jan-Dec.
4
Cannabis Hyperemesis Syndrome in a Young Patient: A Case Report and Literature Review.一名年轻患者的大麻呕吐综合征：病例报告及文献综述
Cureus. 2023 Aug 21;15(8):e43868. doi: 10.7759/cureus.43868. eCollection 2023 Aug.
5
Cannabinoids and the Gastrointestinal Tract.大麻素与胃肠道。
Clin Gastroenterol Hepatol. 2023 Dec;21(13):3217-3229. doi: 10.1016/j.cgh.2023.07.031. Epub 2023 Sep 9.
6
A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong.《癌症舒缓治疗中大麻素呕吐症候群之病例报告：好心可能办坏事》
Oncol Res Treat. 2022;45(7-8):438-443. doi: 10.1159/000524746. Epub 2022 May 3.
7
A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options.大麻相关性恶心呕吐综合征的系统评价及其治疗选择。
Med Princ Pract. 2022;31(1):29-38. doi: 10.1159/000520417. Epub 2021 Nov 1.
8
Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation.大麻素呕吐综合征调查和基因组研究。
Cannabis Cannabinoid Res. 2022 Jun;7(3):336-344. doi: 10.1089/can.2021.0046. Epub 2021 Jul 5.
9
Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.恶心和呕吐的机制：细胞内催吐信号系统的现有知识和最新进展。
Int J Mol Sci. 2021 May 28;22(11):5797. doi: 10.3390/ijms22115797.
10
Management of Pediatric Cannabinoid Hyperemesis Syndrome: A Review.小儿大麻素呕吐综合征的管理：综述
J Pediatr Pharmacol Ther. 2021;26(4):339-345. doi: 10.5863/1551-6776-26.4.339. Epub 2021 May 19.
本文引用的文献
1
Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin.外用辣椒素成功治疗大麻素呕吐综合征
ACG Case Rep J. 2018 Jan 3;5:e3. doi: 10.14309/crj.2018.3. eCollection 2018.
2
Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.大麻素呕吐综合征：急诊科的病理生理学与治疗
J Emerg Med. 2018 Mar;54(3):354-363. doi: 10.1016/j.jemermed.2017.12.010. Epub 2018 Jan 5.
3
Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network.大麻素呕吐综合征：文献综述及法国药物警戒网络报告病例。
Drug Alcohol Depend. 2018 Jan 1;182:27-32. doi: 10.1016/j.drugalcdep.2017.09.038. Epub 2017 Nov 7.
4
US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013.美国成年人非法使用大麻、大麻使用障碍与医用大麻法律：1991 - 1992年至2012 - 2013年
JAMA Psychiatry. 2017 Jun 1;74(6):579-588. doi: 10.1001/jamapsychiatry.2017.0724.
5
Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review.大麻素呕吐综合征的药物治疗：一项系统评价
Pharmacotherapy. 2017 Jun;37(6):725-734. doi: 10.1002/phar.1931. Epub 2017 May 12.
6
Gastroduodenal Disorders.胃十二指肠疾病。
Gastroenterology. 2016 May;150(6):1380-92. doi: 10.1053/j.gastro.2016.02.011.
7
Cannabinoid hyperemesis syndrome: an important differential diagnosis of persistent unexplained vomiting.大麻素呕吐综合征：持续性不明原因呕吐的重要鉴别诊断
Eur J Gastroenterol Hepatol. 2015 Dec;27(12):1403-8. doi: 10.1097/MEG.0000000000000489.
8
Aprepitant and fosaprepitant: a 10-year review of efficacy and safety.阿瑞匹坦和福沙匹坦：疗效与安全性的10年回顾
Oncologist. 2015 Apr;20(4):450-8. doi: 10.1634/theoncologist.2014-0229. Epub 2015 Mar 20.
9
Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome.神经激肽-1 受体拮抗剂阿瑞匹坦治疗儿童周期性呕吐综合征的疗效。
Aliment Pharmacol Ther. 2014 Aug;40(3):309-17. doi: 10.1111/apt.12822. Epub 2014 Jun 5.
10
Cannabinoid hyperemesis: a case series of 98 patients.大麻素呕吐：98 例病例系列。
Mayo Clin Proc. 2012 Feb;87(2):114-9. doi: 10.1016/j.mayocp.2011.10.005.
Zotero 插件